LLY

919.27

+0.07%↑

JNJ

237.65

+0.03%↑

ABBV

207.41

-1.73%↓

NVS

147.84

-2.08%↓

AZN

187.73

-0.86%↓

LLY

919.27

+0.07%↑

JNJ

237.65

+0.03%↑

ABBV

207.41

-1.73%↓

NVS

147.84

-2.08%↓

AZN

187.73

-0.86%↓

LLY

919.27

+0.07%↑

JNJ

237.65

+0.03%↑

ABBV

207.41

-1.73%↓

NVS

147.84

-2.08%↓

AZN

187.73

-0.86%↓

LLY

919.27

+0.07%↑

JNJ

237.65

+0.03%↑

ABBV

207.41

-1.73%↓

NVS

147.84

-2.08%↓

AZN

187.73

-0.86%↓

LLY

919.27

+0.07%↑

JNJ

237.65

+0.03%↑

ABBV

207.41

-1.73%↓

NVS

147.84

-2.08%↓

AZN

187.73

-0.86%↓

Home・Elenco Azioni・Microbot Medical Inc

Microbot Medical Inc

Aperta

2.53 -4.53

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

2.45

Massimo

2.69

Metriche Chiave
By Trading Economics
Entrata	-77K -3.6M
Dipendenti	20
EBITDA	-79K -3.6M

Raccomandazioni
By TipRanks
Raccomandazioni	Fortemente da comprare
Previsioni per 12 mesi	+171.74% upside

Dividendi
By Dow Jones
Utili prossimi	23 mar 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	43M 183M
Apertura precedente	7.06
Chiusura precedente	2.53

Punteggio Tecnico

By Trading Central

Fiducia

Neutral Evidence

2.52 / 2.57 Supporto e resistenza

Microbot Medical Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

18 mar 2026, 22:51 UTC

Utili

AIA Group Value of New Business Rose in 2025, Plans $1.7 Billion New Share Buyback

18 mar 2026, 21:40 UTC

Acquisizioni, Fusioni, Takeovers

Constellation Energy to Sell Portfolio of Assets for $5 Billion to Satisfy Regulators

18 mar 2026, 20:31 UTC

Utili

Micron 2Q Sales Nearly Triple Amid Tight Memory Supply

18 mar 2026, 23:49 UTC

Discorsi di Mercato

Principali Notizie su Eventi

Nikkei May Fall on Renewed Concerns About Higher Energy Prices -- Market Talk

18 mar 2026, 23:31 UTC

Discorsi di Mercato

Gold Rises on Likely Technical Recovery -- Market Talk

18 mar 2026, 22:49 UTC

Discorsi di Mercato

New Zealand's Economic Recovery Has Yet to Find Footing -- Market Talk

18 mar 2026, 22:41 UTC

Discorsi di Mercato

Woodside Energy Opts for 'Safe, Experienced' Choice as CEO -- Market Talk

18 mar 2026, 22:36 UTC

Utili

AIA Group Value of New Business Rose in 2025, Plans $1.7B New Share Buyback

18 mar 2026, 22:24 UTC

Utili

AIA Group Announces New Share Buyback of $1.7B >1299.HK

18 mar 2026, 22:23 UTC

Utili

AIA Group 2025 Value of New Business Margin Was 58.5%, Up 3.6 Ppt on Year >1299.HK

18 mar 2026, 22:23 UTC

Utili

AIA Group 2025 Value of New Business $5.52B Vs. $4.71B >1299.HK

18 mar 2026, 21:58 UTC

Utili

Micron Sales Nearly Triple Amid Tight Memory Supply -- Update

18 mar 2026, 21:55 UTC

Discorsi di Mercato

Utili

Global Equities Roundup: Market Talk

18 mar 2026, 21:55 UTC

Discorsi di Mercato

Utili

Micron's Phone, PC Business Could Shrink Due to Memory Shortage -- Market Talk

18 mar 2026, 21:40 UTC

Discorsi di Mercato

Fuel Price Rise Equates to 20 Bps Rate Hike on Australian Households -- Market Talk

18 mar 2026, 21:16 UTC

Discorsi di Mercato

More Procter & Gamble Alumni Join Strobel at Coty -- Market Talk

18 mar 2026, 21:00 UTC

Principali Notizie su Eventi

Iran War Puts Pressure on Japan's Economy. Takaichi Is In a Bind. -- Barrons.com

18 mar 2026, 20:58 UTC

Utili

Micron 2Q Gross Margin Nearly Doubled Due to Higher Pricing, CFO Says

18 mar 2026, 20:41 UTC

Utili

Micron Reports Extraordinary Earnings. Its Growth Is Accelerating. -- Barrons.com

18 mar 2026, 20:29 UTC

Utili

Micron Reports Extraordinary Earnings. Its Growth Is Accelerating. -- Barrons.com

18 mar 2026, 20:25 UTC

Utili

Micron Reports Extraordinary Earnings. Its Growth Is Accelerating. -- Barrons.com

18 mar 2026, 20:17 UTC

Utili

These Stocks Are Today's Movers: Micron, Swarmer, Lumentum, Trade Desk, Macy's, Williams-Sonoma, and More -- Barrons.com

18 mar 2026, 20:14 UTC

Discorsi di Mercato

Airlines Can't Offset Higher Fuel Prices for Long -- Market Talk

18 mar 2026, 20:09 UTC

Utili

Micron Reports Extraordinary Earnings. The Stock Is Up. -- Barrons.com

18 mar 2026, 20:07 UTC

Utili

Micron Technology Raises Qtr Dividend to 15c Vs. 11.5c >MU

18 mar 2026, 20:06 UTC

Utili

Micron Technology Board Has Approved 30% Increase in Qtrly Div >MU

18 mar 2026, 20:04 UTC

Utili

Micron Technology 2Q Operating Cash Flow $11.9 B >MU

18 mar 2026, 20:04 UTC

Utili

Micron Technology Sees 3Q Operating Expenses About $1.6 B >MU

18 mar 2026, 20:04 UTC

Utili

Micron Technology Sees 3Q Gross Margin About 81% >MU

18 mar 2026, 20:03 UTC

Utili

Micron Technology Sees 3Q Adj EPS $19.15 +/- 40c >MU

Confronto tra pari

Modifica del prezzo

Microbot Medical Inc Previsione

Obiettivo di Prezzo

By TipRanks

171.74% in crescita

Previsioni per 12 mesi

Media 7.5 USD 171.74%

Alto 12 USD

Basso 5 USD

Basato su 3 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Microbot Medical Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

3 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 3 che hanno fornito valutazioni azionarie a Microbot Medical Inc - Dist negli ultimi 3 mesi.

Punteggio Tecnico

By Trading Central

2.52 / 2.57Supporto e resistenza

The bullish and bearish events are balanced.

Recent bullish events outweigh bearish events.

All events are bullish.

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.